Computational and Bioinformatics Techniques for ImmunologyView this Special Issue
Research Article | Open Access
A Mathematical Model of Skeletal Muscle Disease and Immune Response in the mdx Mouse
Duchenne muscular dystrophy (DMD) is a genetic disease that results in the death of affected boys by early adulthood. The genetic defect responsible for DMD has been known for over 25 years, yet at present there is neither cure nor effective treatment for DMD. During early disease onset, the mdx mouse has been validated as an animal model for DMD and use of this model has led to valuable but incomplete insights into the disease process. For example, immune cells are thought to be responsible for a significant portion of muscle cell death in the mdx mouse; however, the role and time course of the immune response in the dystrophic process have not been well described. In this paper we constructed a simple mathematical model to investigate the role of the immune response in muscle degeneration and subsequent regeneration in the mdx mouse model of Duchenne muscular dystrophy. Our model suggests that the immune response contributes substantially to the muscle degeneration and regeneration processes. Furthermore, the analysis of the model predicts that the immune system response oscillates throughout the life of the mice, and the damaged fibers are never completely cleared.
Duchenne muscular dystrophy (DMD) is a lethal, X-chromosome muscle wasting disease affecting approximately one in 3,500 boys [1, 2]. Patients appear clinically normal at birth with the exception of elevated serum creatine kinase levels. The onset of DMD begins in early childhood with the first observed symptoms between two and five years of age. Typically by the age of 12, DMD patients require the use of a wheelchair due to the loss of lower limb muscle strength. Progressive weakness of the arms and legs, along with kyphoscoliosis, continues through late disease progression. Many patients die in their late teens or early twenties due to respiratory or cardiac complications [1, 3]. Currently, there are no effective means of therapy or treatment for DMD.
In 1984, Bulfield et al. identified a spontaneous mutation in C57BL/10ScSn inbred mice that exhibited a disease state similar to human DMD . The X chromosome-linked mutation resulted in mice (mdx mice) with high serum levels of muscle enzymes and with histological lesions comparable to those seen in human muscular dystrophy. This mutation in the murine dystrophin gene caused an absence of dystrophin in skeletal muscle and this key defect validated the mdx mouse as a suitable model of the early onset of DMD human disease [5, 6].
The histology and time course of the disease in mdx mouse model are very different from those in DMD patients: relatively normal life span and overall fitness compared to progressive physical impairment leading to death in DMD patients . Nonetheless, the mdx mouse model is regarded as the best animal model, especially of the early onset of DMD.
Dystrophin deficiency does not always produce muscle degeneration at all life stages, in all muscle phenotypes, or in all animal models . In dystrophin-deficient skeletal muscle, for example, mechanical injury and proteolysis may be important factors but do not fully explain DMD pathogenesis. Mechanisms such as the immune/inflammatory response to injury appear to contribute substantially to muscle pathophysiology. Observations of activated immune cell infiltrates in dystrophic muscle suggest that the immune/inflammatory response may play a role in exacerbating the disease [8–12].
Immune/inflammatory-mediated mechanisms, which result in muscle cell death and/or mechanisms leading to fibrosis, may be important initiators of lesions in dystrophin-deficient muscle. Large populations of lymphocytes, macrophages, and neutrophils are present in DMD muscle tissue . T-cells and macrophages are classically thought to be responsible for triggering and orchestrating the immune response, inducing target cell death, recognizing immune stimuli, and removing cellular debris. Immunosuppressive therapy, such as treatment with glucocorticoids, improves muscle strength and prolongs ambulation in DMD patients but does not prevent disease progression [3, 12]. The article  is a comprehensive literature review of the immune-mediated molecular and signaling mechanisms that regulate the time course of the disease and the mdx mouse model.
One limitation found in the DMD literature is that there are few time course datasets that are consistent for muscle type, ages, or collected with the same methods. To our knowledge, there is not a time course dataset that accounts for the aspects of the immune response, muscle degeneration, and muscle regeneration as modeled herein.
In this paper we presented a simple mathematical model to investigate the role of the immune response in muscle degeneration in mdx mice. The mathematical model represents a novel approach to study DMD pathogenesis and to identify potential therapeutic targets. Using the available data, we constructed a mechanistic differential equations model as the first step toward building a comprehensive model of the immune response in DMD aiming to provide insight into the nature of the immune/inflammatory mechanisms contributing to DMD pathogenesis in the early disease stages. Understanding these underlying mechanisms will provide a key tool to develop effective therapeutic approaches.
The model incorporates the generally held hypothesis that the immune response contributes to muscle tissue damage via CD8+ T-cells that are recruited by macrophages through CD4+ T-cells. This simple model fits the available experimental time course data found in the literature. Moreover, the model suggests that CD8+ T-cells likely contribute to muscle damage and predicts two distinct modes for the long-term dynamics of the immune response.
2. Experimental Techniques and Data
Immune and histopathological time course data used for the model were obtained from available literature. We combined time course data for several different dystrophic muscles for the age range 14–84 days, including those for the concentrations of CD8+ and CD4+ T-cells in quadriceps , macrophages in soleus , procion orange dye uptake (as an indicator of fiber damage) in soleus (SOL) and histopathology in soleus and extensor digitorum longus (EDL) muscles , and TA muscles . It should be noted here that the extensor digitorum longus (EDL) and tibialis anterior (TA) muscles are primarily fast twitch muscles whereas the soleus (SOL) is a slow twitch muscle.
Throughout this paper, we define normal muscle fibers as those that do not exhibit damage; that is, they are neither degenerating nor necrotic, nor do they demonstrate uptake of procion orange dye. Damaged fibers are those that are degenerating or necrotic. Regenerating fibers are those that were damaged and undergoing repair (identified by the presence of centralized nuclei).
3. The Mathematical Model
The model presented here describes in mathematical terms the action of the immune system on muscle tissues subsequent to damage triggered by a not well-specified mechanism. Since we are interested in following the role of the immune system during disease progression, we use a simplistic description of the development of damaged tissue while we model the cell interaction during the buildup of the adaptive (i.e., specific) immune response in more detail. In particular, we include macrophages that trigger T-helper activation enabling cytotoxicity for muscle cells. Whereas macrophages are employed in the removal of damaged cells, favoring tissue regeneration, they also stimulate specific CD8+ lymphocytes that in turn create additional damage. The model is based on the following set of variables: the concentration of immune cells (CD4+, CD8+ T-cells, and macrophages) and the fractions of morphologically normal muscle fibers, damaged muscle fibers, and regenerating muscle fibers in the muscle tissue.
The model variables are immune cells (cell numbers in a cubic millimeter of muscle tissue), macrophages () CD4+ T-helper lymphocytes () and CD8+ cytotoxic T lymphocytes (), and muscle fibers (percentage of the whole muscle tissue): normal (), damaged (), and regenerating fibers ().
The model equations are as follows: Here represents mechanical damage as a lognormal function of time. This damage triggers the cascade of events starting with macrophage infiltration into the tissue, recruitment of CD4+ cells, and activation of CD8+ cells. The choice of a lognormal function to model muscle cell failure comes from considering the accumulation of damage in the muscle tissue as a multiplicative degradation process. In brief, the degradation process leading to a lognormal model is obtained when the amount of degradation or damage that ends in complete failure follows the relationship , where are small independent random shocks (in our case occurring to each single muscle cell) during progression to failure. This relationship means that the increase in the amount of damage from one time point to the next is a small multiple of the total amount of damage accumulated (i.e., fewer undamaged muscle cells have to share the same muscle workload, resulting in a larger effort or stress that yields increased damage at the next time point). When a large number of cells are damaged, by the central limit theorem, the probability of failure can be approximated by a lognormal distribution, or, to be more precise, since failure occurs when the amount of degradation reaches a critical point, the time to failure will be modeled by a lognormal , where , , and are parameters to be determined on the basis of the available experimental data.
For this model, we assume that the physiological damage arising from regular muscular activity is responsible for the initial mechanical damage. Due to genetics and other factors that are determinant in developing the disease, this initial damage is amplified in the mdx mice leading to a strong immune response, while in the wild-type mice (disease-free) the initial damage will not be amplified resulting in a balanced immune response. We model this assumption by simply assuming that, in the wild-type model, the amplitude , which is proportionally related to the mechanical damage, is negligible with respect to its counterpart in mdx mice.
Equations (1)–(3) represent the rate of change of the immune cell counts of CD4+ () and CD8+ T cells () and macrophages (), respectively. In particular, (2) shows that lymphocytes CD8+ T-cells are replenished at a constant rate and die at the rate . The term stands for the activation of CD8+ cells from damaged cells, but only in presence of helper T-cells which activate them. Similarly the term in (1) describes the activation of CD4+ T-cells by macrophages in the presence of damage. Alternatively macrophages in (3) may also be activated by the damage alone (i.e., do not require a second signal).
Equations (4)–(6) represent the rate of change of the percentage of morphologically normal () damaged () and regenerating () muscle fibers. Equation (5) reflects the assumption that the damage accumulates according to the multiplicative degradation process described above with a time-to-failure modeled as a lognormal (term in (4), and the respective term in (5)).
Damaged cells are either removed by the macrophages at rate or by other mechanisms (unspecified) at the rate . Equation (4) indicates that normal cells are replenished from regenerating fibers at the rate and are damaged at the rate by the presence of specific CD8+ T-cells.
Note that (6) can be rewritten as , which is the assumption that a muscle fiber can be either normal, damaged, or regenerating while the total number of fibers in a muscle remains constant.
The model assumes that if there are no damaged muscle fibers in the tissue, the numbers of different immune cells (i.e., CD8+, CD4+ T-cells, and macrophages) do not change. Furthermore, the assumption that the muscle tissue initially has no damaged or regenerating fibers implies the following initial baselines: and .
3.1. Parameter Estimation
In addition to the cell counts at time zero for the three types of immune cells, there are 13 parameters in the model. As nothing is known about the values of these parameters in the literature, especially in a muscle tissue, we estimated their values by fitting, using the freely available software COPASI . COPASI is a stand-alone software for the simulation and analysis of network models and their dynamics. It has many functions, including parameter estimation and sensitivity analysis, both of which we used throughout this study. The optimal parameter values presented in Table 1 were obtained by using particle swarm and the genetic algorithms to search for a global solution. Hooke-Jeeves and Lavenberg-Marquardt algorithms were used to find the best local solution. All of these and many other known optimization algorithms are already implemented in COPASI. We used the immune response experimental data from [9, 11] as well as the muscles data from [14, 15] to estimate the parameters of the model.
We assume that the cell count of any type of the immune cells at time zero in mdx mice is equal to the cell count of that type of immune cell in a wild-type mouse. Based on the available data in the literature about wild-type C57 mice , we assumed that there are initially no CD4+ T-cells, and we set the initial number of macrophages in the tissue to 400 cells and the number of CD8+ T-cells to 4. It should be noted here that the model is not sensitive, however, to any of the initial counts of the immune cells, as we will explain in the next section.
3.2. Model Assessment
Even though the model is simple and includes only the key mechanisms of the immune system, it captures the main features of the known dynamics of mdx dystrophic muscle pathophysiology, and it manages to reproduce the seemingly unrelated experimental datasets that are reported in the literature as shown in Figure 1. The trajectories of the immune cells in the left panel of Figure 1 fit well the known immune response time course data about macrophages in soleus from  and the CD4+ and CD8+ T-cells from , while at the same time, the figures in the right panel of Figure 1 show that the model trajectories of the different muscle tissue types are in good agreement with the SOL time course from  and the TA time course from .
As mentioned above, the initial counts of the immune cells in the model are set to be equal to those of the wild-type mice. This assumption, however, might not actually be the case for the mdx mouse, as the immune response might have started during gestation (prior to birth). To see the effects of onset of the immune response during gestation on the model curves and to explore the sensitivity of the model to these parameters, we varied the values of the three counts and calculated the new trajectories of the 5 variables of the model. Figure 4 shows the trajectories of macrophages and damaged fibers of 125 different sets of initial values of the three immune cell types. These random values were picked from ranges determined from the available data from wild-type mice. It is clear that these trajectories are qualitatively the same as the corresponding trajectories in Figure 1. This outcome shows that the model is insensitive to the initial counts of immune cells.
3.3. Model Prediction
As shown in Figure 1, our model trajectories are in good agreement with the available mdx mice datasets. Furthermore, the wild-type datasets are in good agreement with our model as shown in Figure 2, where the amplitude of the mechanical damage in the disease-free mice (wild-type) is one tenth of its counterpart in the mdx mice.
To test the model sensitivity to its parameters, we varied the parameters’ values from within their ranges as reported in Table 2. For each of the listed parameters, two values were chosen from within the range of that parameter. This approach resulted in more than 1000 parameter sets. Figure 5 shows the dynamics of macrophages and normal fibers resulting from a sample of these sets. It is clear in Figure 5 that, for the first 7 weeks, the trajectories are qualitatively the same for all parameter sets. However, for the weeks after, and for most of the parameter sets, we see oscillation both in the immune response as well as the different types of muscle fibers.
The literature suggests that “cycles” of muscle degeneration and regeneration contribute to progressive muscle wasting [18–20] which is likely antagonized further by the immune response [8–12]. This relationship suggests a predator-prey-like interaction between the immune system and the tissue, which has been reported in many other diseases . After the dramatic increase of the immune cells and the initial peak of damage in the first 4–8 weeks, the immune cells decrease; muscle degeneration and regeneration cycles are suppressed but continue at low levels. This scenario or mode is captured in Figure 5, by many parameter sets, where oscillation with low amplitude is persistent in the immune response as well as the normal fibers.
For almost all other parameter sets, another mode emerged: the system escapes the oscillatory behavior above and slowly approaches a disease-free state where the percentages of damaged and regenerating fibers will both be very small, and almost all tissue fibers are normal.
This could be the result of a significant decrease of the immune response. In this case, even though regeneration is slow, pathophysiology decreases and degeneration diminishes, which may further suppress the immune response.
The time course for the dystrophic process in mdx mice for the first year of life includes muscle degeneration/regeneration cycles between the age of 3 and 10 weeks, followed by a decrease in these cycles and relative muscle stability to the age of ~1 year . The outcomes of the model represented by both modes appear to account for the attenuation of the dystrophic process in mice after the age of ~10 weeks.
Furthermore, the model predicts that the dynamics could switch between the two modes in a response to a change in some of the key parameters, such as the rate at which regenerating fibers become normal.
3.4. Immune Cell Depletions
Elevated concentrations of macrophages (>80,000 cells/mm3, normal ~1000 cells/mm3) have been observed in 4–8 weeks mdx mouse muscle but rapidly decrease by 12 weeks [9, 11, 15]. Macrophages have a variety of immunoregulatory and inflammatory functions. They are rich sources of cytokines and nitric oxide, a potent-free radical that can lyse muscle cells. Macrophages are antigen-presenting cells, which may regulate the immune response in dystrophic muscle and could possibly activate T-cells. Antibody-mediated depletion of macrophages, beginning at 6 days old and continuing to 4 weeks in mdx mice, resulted in a >75% reduction of injured muscle fibers, suggesting an important role of these cells in the development of lesions .
Elevated concentrations of activated CD8+ and CD4+ T-cells are observed in affected muscles of mdx mice at the age of 4–8 weeks, but rapidly decrease by 14 weeks (>1200 cells/mm3 in mdx muscle, normal ~100 cells/mm3) [9, 15]. Antibody-mediated depletion of CD8+ or CD4+ T-cells in mdx mice, beginning at 6 days old and continuing to 4 weeks of age, resulted in a 75% and 61% reduction in muscle pathology, respectively, for mice at the peak of disease progression .
According to the model construction, CD8+ T-cells contribute to damage and are produced mainly in response to increased numbers of macrophages; hence, depleting macrophages should reduce the percentage of CD8+ T-cells in the tissue which will do two things: (i) there will be no damage due to CD8+ T-cells, but it also means that there will be no macrophages to clear the damaged cells; (ii) in the model, the macrophage contribution to clearing out the damage is high and so depleting the macrophages will initially increase the damage but then the damage decreases as shown in Figure 6.
Figure 6(a) shows that macrophage depletion in the model resulted in improved muscle tissue with 86% of the muscle fibers characterized as normal. It should be noted here that the percentage of damaged fibers in Figure 6(b) in the tissue is not much lower than the one in Figure 1(d). This outcome may not be surprising since depleting macrophages yields fewer CD8+ T-cells and hence fewer degenerating fibers. At the same time, however, there will be fewer CD4+ T-cells and hence less stimulus to promote the regenerating process.
4. Discussion and Conclusions
Immune response is known to play a key role in exacerbating the disease in DMD patients and mdx mice. Indeed, a primary treatment for DMD patient is glucocorticoids (GC) whose main effect is the inhibition of numerous inflammatory genes. Even though mdx mice show a mild phenotype and do not accurately reflect the severe nature of the human disease, they are considered a reasonable model. In mdx mice, several studies demonstrated that depletion of immune cells results in improvement of dystrophic muscle pathophysiology; however, the role and time course of the immune response in the dystrophic process have not been well described. Even though there are time course datasets from different muscles that account for different features of the disease, to our knowledge, there is not a single time course that accounts for both the immune response and muscle pathophysiology in the same muscle type.
We have presented a mathematical model of the immune response to the skeletal muscle wasting and inflammation in mdx mice. Our model is simple in the sense that it contains only the basic mechanisms of the immune response and its known interactions with dystrophic muscle. Nonetheless, our model reproduces available data from different experimental studies. Furthermore, the depletions of the immune cells in the model result in an increased percentage of normal fibers as observed in different experiments on mdx mice.
The dynamics of the tuned system shows one main behavior in which the immune system contributes to damage in recurring phases of muscle destruction. However, by changing some crucial parameters’ values (in particular parameters , , and ) the frequencies of these relapses can be modified eventually obtaining a mode in which the disease is controlled, where damaged fibers regenerate but slowly. The above three parameters are the damaged-driven proliferation rates of CD4+, CD8+ T-cells, and the cytotoxicity of CD4+ T-cells, which are key drivers of the damage in the model. Figure 7 shows the dependency on of the trajectories of damaged, regenerating, and normal fibers. As the value of increases, both the percentage of damaged fibers and the intensity of the immune response increase, leading to an accumulation of regeneration fibers during the period of 5–7 weeks, and this results in an oscillatory behavior where the damage is persistent and around 75 percent of the tissue is regenerating. Similar curves appear when we performed the same analysis using or .
The heat maps in Figure 8 show the asymptotic (at week 50) percentages of normal and regenerating when the parameters and are changed together. The two main regimes are found for extreme values of the two parameters going from regenerating to normal by increasing both and . It clearly shows that, by increasing both parameters together, the percentage of normal (regenerating, resp.) would increase (decrease, resp.) at a faster rate than increasing one parameter only. Furthermore, it is easy to see that a small decrease in any of the two parameters would lead to the oscillatory behavior where the majority of the fibers are regenerating.
Another crucial parameter is the rate at which a regenerating fiber returns, in our model, to morphologically normal muscle fiber, , which is low indicating a slow regeneration process. Once a fiber is damaged, it could take weeks before it returns to a morphologically normal muscle fiber. This could explain the high percentage of regenerating fibers observed in dystrophic muscles. The model is sensitive to this parameter. Figure 9 shows how the percentages of damage, regenerating, and normal tissue change when varying . As we increase the value of , the normal tissue asymptotically increases (see Figure 9(c)). However, beyond an optimal value, for which the normal cells are about 100% of the total, the percentage of normal tissues falls to and oscillates around 30%. The other two panels of the same figure show the analogous outcome on damage and regenerating tissue.
In conclusion, although simple, and also considering the limited experimental data, the present model suggests theoretical points of intervention, although the way to achieve the predicted effects through therapeutics may be difficult. This difficulty arises in part because our model does not include additional details such as the relevant signaling pathways, for example, NF-kB, the changes in the population of M1 and M2 macrophages, nor does it keep track of the many potential cytokines and chemokines that are involved.
Nevertheless, the discussion above suggests potential treatment approaches. For example, a treatment approach would decrease antigen presentation by macrophages, thus reducing T-helper activation and consequent cytotoxic stimulation (parameters and ); a second approach attenuates the destruction of normal tissue by cytotoxic T-cells (parameter ), while a third approach would drive the generation rate of healthy fibers to near optimal. In practical terms, however, the suggested therapeutic approaches may not be effective because the model lacks many additional and critical details as noted above. It would be interesting to investigate whether a modification of the model to account for the aforementioned deficits would still identify limiting antigen presentation or cytotoxicity as the main potential candidates for mitigating the immune system effects on the dystrophic pathophysiology.
Conflict of Interests
The authors declare that there is no conflict of interests.
Abdul Salam Jarrah and Filippo Castiglione contributed equally to this work.
The authors thank the referee for the valuable comments and suggestions. Abdul Salam Jarrah thanks Stafan Hoops for his help with the software COPASI. Abdul Salam Jarrah was partially supported by a faculty research grant (FRG3). Filippo Castiglione thanks the European Commission for partially funding this study under the 7th Framework Programme (MISSION-T2D project no. 600803).
- D. J. Blake, A. Weir, S. E. Newey, and K. E. Davies, “Function and genetics of dystrophin and dystrophin-related proteins in muscle,” Physiological Reviews, vol. 82, no. 2, pp. 291–329, 2002.
- J. G. Tidball and M. Wehling-Henricks, “Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events,” Pediatric Research, vol. 56, no. 6, pp. 831–841, 2004.
- A. E. H. Emery, “The muscular dystrophies,” The Lancet, vol. 359, no. 9307, pp. 687–695, 2002.
- G. Bulfield, W. G. Siller, P. A. L. Wight, and K. J. Moore, “X chromosome-linked muscular dystrophy (mdx) in the mouse,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 4, pp. 1189–1192, 1984.
- M. Durbeej and K. P. Campbell, “Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models,” Current Opinion in Genetics and Development, vol. 12, no. 3, pp. 349–361, 2002.
- C. A. Collins and J. E. Morgan, “Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies,” International Journal of Experimental Pathology, vol. 84, no. 4, pp. 165–172, 2003.
- T. A. Partridge, “The mdx mouse model as a surrogate for Duchenne muscular dystrophy,” The FEBS Journal, vol. 280, no. 17, pp. 4177–4186, 2013.
- J. D. Porter, W. Guo, A. P. Merriam et al., “Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle,” Neuromuscular Disorders, vol. 13, no. 3, pp. 223–235, 2003.
- M. J. Spencer, C. M. Walsh, K. A. Dorshkind, E. M. Rodriguez, and J. G. Tidball, “Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin- mediated cytotoxicity,” The Journal of Clinical Investigation, vol. 99, no. 11, pp. 2745–2751, 1997.
- M. J. Spencer and J. G. Tidball, “Do immune cells promote the pathology of dystrophin-deficient myopathies?” Neuromuscular Disorders, vol. 11, no. 6-7, pp. 556–564, 2001.
- M. Wehling, M. J. Spencer, and J. G. Tidball, “A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice,” Journal of Cell Biology, vol. 155, no. 1, pp. 123–132, 2001.
- J. D. Porter, S. Khanna, H. J. Kaminski et al., “A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice,” Human Molecular Genetics, vol. 11, no. 3, pp. 263–272, 2002.
- N. P. Evans, S. A. Misyak, J. L. Robertson, J. Bassaganya-Riera, and R. W. Grange, “Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention,” PM&R, vol. 1, no. 8, pp. 755–768, 2009.
- N. P. Evans, J. A. Call, J. Bassaganya-Riera, J. L. Robertson, and R. W. Grange, “Green tea extract decreases muscle pathology and NF-κB immunostaining in regenerating muscle fibers of mdx mice,” Clinical Nutrition, vol. 29, no. 3, pp. 391–398, 2010.
- M. J. Spencer, E. Montecino-Rodriguez, K. Dorshkind, and J. G. Tidball, “Helper (CD4+) and cytotoxic (CD8+) T cells promote the pathology of dystrophin-deficient muscle,” Clinical Immunology, vol. 98, no. 2, pp. 235–243, 2001.
- A. N. Kolmogorov, “Uber das logarithmisch normale Verteilungsgesetz der Dimensionen der Teilchen bei Zerstuckelung,” Doklady Akademii Nauk, vol. 31, pp. 99–101, 1941.
- S. Hoops, R. Gauges, C. Lee et al., “COPASI—a COmplex PAthway SImulator,” Bioinformatics, vol. 22, no. 24, pp. 3067–3074, 2006.
- Y. Tanabe, K. Esaki, and T. Nomura, “Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse,” Acta Neuropathologica, vol. 69, no. 1-2, pp. 91–95, 1986.
- J. X. DiMario, A. Uzman, and R. C. Strohman, “Fiber regeneration is not persistent in dystrophic (mdx) mouse skeletal muscle,” Developmental Biology, vol. 148, no. 1, pp. 314–321, 1991.
- T. Yokota, Q.-L. Lu, J. E. Morgan et al., “Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration,” Journal of Cell Science, vol. 119, no. 13, pp. 2679–2687, 2006.
- J. Stark, C. Chan, and A. J. T. George, “Oscillations in the immune system,” Immunological Reviews, vol. 216, no. 1, pp. 213–231, 2007.
- T. J. Hawke, A. P. Meeson, N. Jiang et al., “p21 is essential for normal myogenic progenitor cell function in regenerating skeletal muscle,” American Journal of Physiology—Cell Physiology, vol. 285, no. 5, pp. C1019–C1027, 2003.
Copyright © 2014 Abdul Salam Jarrah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.